Biotechnology startup

SIMULATE

SIMULATE's mission is to upgrade the world to a positive food system.

Funding reportedLast round: Series B

BiotechnologyNew York

What company datasets say SIMULATE raised

Funding, as reported

Reported in all57Min the source's currency
Rounds2
Last roundSeries B
Last round dateJun 2021
Investors listed25
SEC Form D$29M sold, 1 filing, last Jul 2021

Founders and team

From SIMULATE's own website: 1 founder, 3 on the team.

Andrew RosenerFounder and Chairman
  • Jonathan TenenbaumCEO & General Counsel
  • Sofía CanalaVP of Business Operations
  • William TenenbaumDirector of Marketing

On 5 portfolio pages

Investors who name them

Each firm lists SIMULATE on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in the same market

Startups like it

Is this your company?

Add your raise, your deck and your story, and put SIMULATE in front of investors. Or tell us what we have wrong.